Analysts expect over 2020 rising revenue Bristol-Myers Squibb

Over the current book year the total revenue will be 41,97 billion USD (consensus estimates). This is rather significant more than 2019's revenue of 26,15 billion USD.

Historical revenues and results Bristol-Myers Squibb plus estimates 2020

The analysts expect for 2020 a net profit of 14,44 billion USD. The majority of the analysts expects for this year a profit per share of 6,27 USD. So the price/earnings-ratio equals 9,69.

Per share the analysts expect a dividend of 1,8 USD per share. Thus the dividend yield equals 2,96 percent. The average dividend yield of the pharmaceutical companies is a limited 0,38 percent.

Bristol-Myers Squibb's market capitalization is based on the number of outstanding shares around 98,69 billion USD. The Bristol-Myers Squibb stock was the past 12 months quite unstable. Since last October the stock is 19 percent higher. This year the stock price moved between 46 and 68 dollar.

Historical stock prices Bristol-Myers Squibb2007-2020

Click here for dividend Bristol-Myers Squibb. At 22.10 the stock trades 0,77 percent lower at 60,77 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.